ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 98 filers reported holding ENDOCYTE INC in Q1 2015. The put-call ratio across all filers is 2.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $519,000 | -41.8% | 29,231 | -54.7% | 0.00% | -50.0% |
Q2 2018 | $891,000 | +1436.2% | 64,588 | +375.7% | 0.01% | – |
Q4 2017 | $58,000 | +141.7% | 13,578 | -19.8% | 0.00% | – |
Q3 2017 | $24,000 | 0.0% | 16,920 | +7.0% | 0.00% | – |
Q2 2017 | $24,000 | +380.0% | 15,820 | +890.6% | 0.00% | – |
Q1 2016 | $5,000 | -92.9% | 1,597 | -88.1% | 0.00% | -100.0% |
Q2 2015 | $70,000 | -68.3% | 13,427 | -61.8% | 0.00% | -66.7% |
Q4 2014 | $221,000 | -44.5% | 35,138 | -46.3% | 0.00% | -50.0% |
Q3 2014 | $398,000 | +107.3% | 65,487 | +355.1% | 0.01% | +50.0% |
Q3 2013 | $192,000 | +700.0% | 14,389 | +692.8% | 0.00% | +300.0% |
Q2 2013 | $24,000 | – | 1,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
Leisure Capital Management | 28,304 | $121,000 | 0.10% |
Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |